Market Cap 6.66M
Revenue (ttm) 730,000.00
Net Income (ttm) -9.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,261.64%
Debt to Equity Ratio 0.00
Volume 38,800
Avg Vol 78,600
Day's Range N/A - N/A
Shares Out 2.49M
Stochastic %K 39%
Beta 1.94
Analysts Strong Buy
Price Target N/A

Latest News on MGRX

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Oct 21, 2024, 5:10 PM EDT - 3 months ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly


Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Jul 18, 2024, 4:05 PM EDT - 6 months ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access